Follow-The-Filings

Security · featured owners

ALNY Alnylam Pharmaceuticals Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.3%
  • $589M
  • 1 add 1 reduce

ALNY (Alnylam Pharmaceuticals Inc.) is held in 2 featured 13F books as of 2026 Q2. Dodge & Cox is the largest tracked holder by portfolio weight (0.31%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (Dodge & Cox) · not free-float ownership

  1. Dodge & Cox add 0.31%
  2. Murray Stahl reduce 0.01%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Dodge & Cox 2026 Q2 0.31% Add +1.4% 1,955,393 $589M history
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 0.01% Reduce −4.6% 2,168 $653K history

2 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 7 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 7 rows shown

Filed Form Detail Links
4 Period Jun 1, 2026 · 2 forms Filing Doc
4 Period May 20, 2026 · 9 forms Filing Doc
4 Period May 13, 2026 Filing Doc
4 Period Apr 2, 2026 Filing Doc
4 Period Mar 4, 2026 · 5 forms Filing Doc
4 Period Mar 2, 2026 · 6 forms Filing Doc
4 Period Feb 27, 2026 Filing Doc

Updated about 1 month ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.83B $2.25B $3.71B
Gross profit * $1.56B $1.94B $3.04B
Gross margin * 85.3% 86.4% 81.8%
Net income -$440.24M -$278.16M $313.75M
Net margin * -24.1% -12.4% 8.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.98B $3.3B $4.05B
Total non-current assets * $847.18M $944.7M $915.67M
Total assets $3.83B $4.24B $4.97B
Total current liabilities $0.968B $1.19B $1.47B
Total non-current liabilities * $3.08B $2.99B $2.71B
Total equity -$220.64M $67.09M $789.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $104.16M -$8.31M $524.08M
Cash from investing -$336.35M -$116.84M $436.33M
Cash from financing $172.13M $294.16M -$305.19M
Net change in cash -$53.67M $153.77M $690.16M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders